| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Yuyu Pharma, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩4,825.00 |
| 52 Week High | ₩7,440.00 |
| 52 Week Low | ₩4,120.00 |
| Beta | 0.56 |
| 11 Month Change | -2.43% |
| 3 Month Change | -0.62% |
| 1 Year Change | 0.42% |
| 33 Year Change | -45.73% |
| 5 Year Change | -6.31% |
| Change since IPO | 471.24% |
Recent News & Updates
Concerns Surrounding Yuyu Pharma's (KRX:000220) Performance
Aug 24
Pinning Down Yuyu Pharma, Inc.'s (KRX:000220) P/S Is Difficult Right Now
Aug 07Recent updates
Concerns Surrounding Yuyu Pharma's (KRX:000220) Performance
Aug 24Pinning Down Yuyu Pharma, Inc.'s (KRX:000220) P/S Is Difficult Right Now
Aug 07Here's Why Yuyu Pharma (KRX:000220) Has A Meaningful Debt Burden
Apr 02Should Yuyu Pharma, Inc. (KRX:000220) Be Part Of Your Dividend Portfolio?
Mar 08The Yuyu Pharma (KRX:000220) Share Price Has Gained 12% And Shareholders Are Hoping For More
Feb 10
We Wouldn't Rely On Yuyu Pharma's (KRX:000220) Statutory Earnings As A Guide
Jan 07Yuyu Pharma (KRX:000220) Seems To Use Debt Quite Sensibly
Dec 20Would Yuyu Pharma, Inc. (KRX:000220) Be Valuable To Income Investors?
Dec 03Shareholder Returns
| A000220 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -2.2% | 5.1% | -0.5% |
| 1Y | 0.4% | 21.0% | 0.6% |
Return vs Industry: A000220 underperformed the KR Pharmaceuticals industry which returned 21% over the past year.
Return vs Market: A000220 matched the KR Market which returned 0.6% over the past year.
Price Volatility
| A000220 volatility | |
|---|---|
| A000220 Average Weekly Movement | 5.7% |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in KR Market | 12.1% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A000220 has not had significant price volatility in the past 3 months.
Volatility Over Time: A000220's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1941 | 253 | Robert Yu | www.yuyu.co.kr |
Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Jecheon-si, South Korea.
Yuyu Pharma, Inc. Fundamentals Summary
| A000220 fundamental statistics | |
|---|---|
| Market cap | ₩78.08b |
| Earnings (TTM) | ₩2.57b |
| Revenue (TTM) | ₩135.28b |
30.3x
P/E Ratio0.6x
P/S RatioIs A000220 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A000220 income statement (TTM) | |
|---|---|
| Revenue | ₩135.28b |
| Cost of Revenue | ₩86.01b |
| Gross Profit | ₩49.27b |
| Other Expenses | ₩46.70b |
| Earnings | ₩2.57b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 159.08 |
| Gross Margin | 36.42% |
| Net Profit Margin | 1.90% |
| Debt/Equity Ratio | 27.0% |
How did A000220 perform over the long term?
See historical performance and comparison